IQVIA (IQV) vs NRC Health (NRC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
NRC Health (NRC) has outperformed IQVIA (IQV) over the past year, gaining 71.3% versus a gain of 29.1%. Over five years, IQV leads with a +4.0% price change compared with -52.4% for NRC. IQVIA is the larger company by market cap ($42.61 billion vs $451.7 million), about 94.3 times the size.
On valuation, IQVIA trades at a lower forward P/E (17.9x vs 19.4x for NRC Health). NRC Health pays a dividend yielding 2.94%, while IQVIA does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IQV | NRC |
|---|---|---|
| Share price | $258.88 | $20.42 |
| Market cap | $42.61B | $451.68M |
| 1-day change | +0.30% | +1.14% |
| YTD return | +14.85% | +8.79% |
| 1-year return | +29.05% | +71.31% |
| 5-year return | +4.03% | -52.38% |
| P/E ratio (TTM) | 32.16 | 85.08 |
| Forward P/E | 17.94 | 19.45 |
| EPS (TTM) | $8.05 | $0.24 |
| Dividend yield | 0.00% | 2.94% |
| Annual dividend | $0.00 | $0.60 |
| Revenue (latest FY) | $16.31B | — |
| Revenue growth (YoY) | +5.87% | — |
| Net income (latest FY) | $1.36B | — |
| Gross margin | 33.29% | — |
| Operating margin | 13.38% | — |
| Net margin | 8.34% | — |
| 52-week high | $277.40 | $23.68 |
| 52-week low | $154.50 | $11.01 |
| Distance from 52-week high | -6.68% | -13.77% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +12.35% | +27.33% |
| Average volume | 1.45M | 115.97K |
| Shares outstanding | 164.60M | 22.12M |
| Employees | 94,000 | 357 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Biotechnology: Commercial Physical & Biological Resarch |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IQVIA is about 94.3 times larger than NRC Health by market value ($42.61B vs $451.68M).
- NRC has outperformed IQV by 42.3 percentage points over the past year.
- NRC Health trades at a higher earnings multiple (85.1x vs 32.2x trailing P/E).
- NRC Health offers a meaningfully higher dividend yield (2.94% vs 0.00%).
About IQVIA
IQV stock →IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 94,000 employees
About NRC Health
NRC stock →NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 357 employees
IQV vs NRC FAQ
Which is bigger, IQVIA or NRC Health?
IQVIA (IQV) is larger, with a market capitalization of $42.61B compared with $451.68M for NRC Health (NRC).
Which stock has performed better over the past year, IQV or NRC?
NRC returned +71.31% over the past 12 months, compared with +29.05% for IQV (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, IQV or NRC?
IQV has the lower trailing P/E at 32.2, versus 85.1 for NRC. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, IQVIA or NRC Health?
NRC Health pays a dividend yielding 2.94%, while IQVIA does not currently pay a regular dividend.
Are IQVIA and NRC Health in the same industry?
Yes. Both are classified in the Biotechnology: Commercial Physical & Biological Resarch industry within the Health Care sector.